- China: Low US Interest Rates Threaten Recovery
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- White House Plans to Freeze Spending to Cut Deficit
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Cities With the Most Home Price Reductions
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- This Year's Biggest Thanksgiving Leftover: Cash
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
MOST SHARED
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Today's Market Action
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- CNBC TRANSCRIPT: Warren Buffett & Bill Gates - Keeping America Great
- Israel Going Green
- Inside Wal-Mart's Acai Berry Juice Maker
- China's Role as Lender Alters Dynamics for United States
Text Size 
Investors could get good returns in the health-care sector and use it to protect themselves from wild price swings in other areas if they pick the right shares, despite the fact that many big-cap health-care stocks took a battering in 2007, Luis Correia, fund manager at Clariden Leu, told "Squawk Box Europe" Monday.
 |
AP |
Pharmacy benefit management companies, which are third-party administrators for drug programs, are a good bet, Correia said, because they benefit from the shift to generic drugs. Clariden Leu’s best performing fund in 2007 was focused on the growing generic sub-sector.
"Investors should not just play the sector by buying a few of the large-cap pharma stocks, they might again be disappointed," Correia said.
"They really need to look deeper into the sector, looking to sub-sectors like health-care services … the same is valid for medical technology and bio-technology," he added.
Watch for New Products
Correia said a rule of thumb was to look at new product cycles to decide which stocks would yield results.
"As long as companies are able to introduce new products … they will also deliver very interesting investment performances," he said.
Correia added that the health-care sector may face a possible setback if Barack Obama becomes the next U.S. president, because the Democrats have previously been vocal about reforming the Medicaid system and bringing down product prices.
"There is a certain risk, this is another reason why we need to be careful where we invest, we need to pick stocks which are less vulnerable on pricing pressure," he said.
Beaten-down large-cap pharma stocks such as the UK’s AstraZeneca could provide opportunities, because they are at very low valuations, Correia added: "The only way these stocks can go is up and the way they would go up by a positive surprise from their research and development effort."
Print
Email
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
- A wealthy, distracted Texas driver crashed his million-dollar Bugatti Veyron sports car into a salt marsh, say police.
Data is a real-time snapshot *Data is delayed at least 15 minutes